Glaxo Wellcome Production
PolandAll drugs from this manufacturer
-
Amoxil is an antibiotic used to treat infections caused by bacteria in various parts of the body. It may also be used in combination with other medicines to treat peptic ulcer disease.
Dosage form: powder for preparation of oral suspension
Active substance Dosage sodium amoxicillin 292.4 mg/5 ml ATC: J01CA04
-
Amoxil is an antibiotic used to treat infections caused by bacteria in various parts of the body. It may also be used in combination with other medicines to treat peptic ulcer disease.
Dosage form: powder for preparation of oral suspension
Active substance Dosage amoxicillin 584.8 mg/5 ml ATC: J01CA04
-
This is an antibiotic used in adults and children for the treatment of infections of the middle ear, paranasal sinuses, respiratory tract, urinary tract, skin, soft tissues (including dental), and bones and joints.
Dosage form: tablets, film-coated
Active substance Dosage amoxicillin trihydrate 500 mg clavulanic acid 125 mg ATC: J01CR02
-
This is an antibiotic used in adults and children for the treatment of, among others, infections of the middle ear, paranasal sinuses, respiratory tract, urinary tract, skin, soft tissues (including dental), and bones and joints.
Dosage form: tablets, film-coated
Active substance Dosage amoxicillin 875 mg potassium clavulanate 125 mg ATC: J01CR02
-
This medicine is an antibiotic used in infants and children to treat middle ear infections and lung infections.
Dosage form: powder for preparation of oral suspension
Active substance Dosage amoxicillin 600 mg/5 ml clavulanic acid potassium 42.9 mg/5 ml ATC: J01CR02
-
This is an antibiotic used in adults and children for the treatment of infections of the middle ear, paranasal sinuses, respiratory tract, urinary tract, skin, soft tissues (including dental), and bones and joints.
Dosage form: powder for preparation of oral suspension
Active substance Dosage amoxicillin 400 mg/5 ml clavulanic acid 57 mg/5 ml ATC: J01CR02
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg ATC: R03BA05
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 50 mcg ATC: R03BA05
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also indicated for the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg ATC: R03BA05
-
The medicine is used to prevent asthma attacks in adults and children over 4 years of age. It is also used in the treatment of chronic obstructive pulmonary disease (COPD) in combination with another medicine (salmeterol).
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg ATC: R03BA05
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 125 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
-
The medicine is used to prevent breathing difficulties occurring in asthma. It helps to prevent shortness of breath and wheezing.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
-
The medicine is used to prevent breathing disorders occurring in asthma. It helps to maintain airway patency and reduces lung swelling and irritation.
Dosage form: aerosol, inhalation suspension
Active substance Dosage fluticasone propionate 50 mcg salmeterol xinafoate 25 mcg ATC: R03AK06
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces lung swelling and irritation.
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 100 mcg/dose inh. salmeterol xinafoate 50 mcg/dose inh. ATC: R03AK06
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 250 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
-
The medicine is used to prevent breathing difficulties occurring in asthma and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open and reduces swelling and irritation in the lungs.
Dosage form: powder for inhalation
Active substance Dosage fluticasone propionate 500 mcg salmeterol xinafoate 50 mcg ATC: R03AK06
-
The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal attacks) and chronic obstructive pulmonary disease (COPD). It helps to keep the airways open, facilitating airflow. It may also help to interrupt episodes of shortness of breath or wheezing, but it does not act immediately.
Dosage form: powder for inhalation
Active substance Dosage salmeterol xinafoate 72.5 mcg ATC: R03AC12
-
The medicine is used to treat breathing disorders in adults, adolescents, and children from 4 years of age suffering from asthma or similar conditions. It helps to dilate the bronchi, facilitate breathing, and reduce chest tightness, coughing, and wheezing. It can also be used to prevent asthma symptoms triggered by physical exertion or contact with allergens (e.g., dust, pollen, or cigarette smoke).
Dosage form: powder for inhalation
Active substance Dosage salbutamol sulfate 200 mcg ATC: R03AC02